Salman Andac, Sarac Gonca, Can Kuru Burce, Cinel Leyla, Yucelten Ayse Deniz, Ergun Tulin
Department of Dermatology, School of Medicine, Marmara University, Istanbul, Turkey.
Department of Dermatology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey.
Pediatr Dermatol. 2017 Nov;34(6):e302-e304. doi: 10.1111/pde.13283. Epub 2017 Sep 21.
Acquired progressive lymphangioma (APL), or benign lymphangioendothelioma, is an unusual entity derived from vascular structures. Clinically and histopathologically it may resemble Kaposi's sarcoma and well-differentiated angiosarcoma, causing a diagnostic problem. We report an individual with APL initially diagnosed with Kaposi's sarcoma who underwent unnecessary laboratory testing. Imiquimod 5% cream stopped the progression of the lesion. Awareness of this rare entity may prevent patients from undergoing excessive testing. Imiquimod may be used as a safe, effective treatment option.